Riskpilot← Back to searchSign inGet full accessVithal Health AB
ABActiveOrg 5590924345Apelsingatan 73Hospital activities · NACE 8610Est. 20161-4 employees
Revenue 2025
SEK 732K
+248% vs 2024
EBITDA margin
39.7%
+165% vs 2024
Equity ratio
52.2%
Financial strength
Net profit 2025
SEK 214K
+150% vs 2024
| Revenue | SEK 732K | +248% |
| EBITDA | SEK 291K | +165% |
| Net profit | SEK 214K | +150% |
| Total assets | SEK 507K | +175% |
| Equity | SEK 264K | +95% |
| Employees | — | — |
Legal name
Vithal Health AB
Org number
5590924345
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
19 december 2016
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet och utbildning inom hälso- och sjukvård samt därmed förenlig verksamhet. Estetisk kirurgi samt därmed förenlig verksamhet
Address
Apelsingatan 73
Email
richard.vithal@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 107 | 228 | 210 | 732 |
| Staff expenses | — | −16 | −1 | −0 | −76 |
| EBITDA | −21 | −13 | 148 | 109 | 291 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −21 | −13 | 148 | 109 | 291 |
| Net financials | — | −0 | −0 | −1 | −1 |
| Profit before tax | −22 | −14 | 148 | 109 | 290 |
| Tax | −0 | −0 | −32 | −23 | −76 |
| Net profit | −22 | −14 | 115 | 86 | 214 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 65 | 50 | 265 | 184 | 507 |
| Equity | 28 | 14 | 130 | 136 | 264 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 37 | 36 | 135 | 48 | 242 |
| Total debt | 37 | 36 | 135 | 48 | 242 |
EBITDA margin
39.7%
This company
15.8%
Market median
+151% vs market
20212025
Equity ratio
52.2%
This company
38.2%
Market median
+37% vs market
20212025
Return on equity
81.1%
This company
18.4%
Market median
+341% vs market
20212025
Net profit margin
29.3%
This company
8.1%
Market median
+262% vs market
20212025
Asset turnover
1.45×
This company
1.12×
Market median
+29% vs market
20212025
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vithal Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michelle R K Vithal Bergström | Deputy Board Member | 0 companies |
| Emma Linnéa Vithal | Deputy Board Member | 0 companies |
| Richard Charles Vithal | Board of Directors | 0 companies |